Close

Spark Therapeutics (ONCE), Pfizer (PFE) Announce Presentation of Updated SPK-9001 Phase 1/2 data in Hemophilia B

November 3, 2016 9:06 AM EDT Send to a Friend
Spark Therapeutics (Nasdaq: ONCE) and Pfizer Inc. (NYSE: PFE) announced that Lindsey A. George, M.D., a hematologist and attending physician ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login